Vimarsana
Biggest News Aggregation in the World

Page 46 - Michael Erman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michael Erman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michael Erman Today - Breaking & Trending Today

Around 1.8 million Americans received COVID shots last week-IQVIA - Vimarsana News

Around 1.8 million Americans received COVID shots last week-IQVIA

(Reuters) - Around 1.8 million people in the United States received a COVID vaccine during the week ended Sept. 22, according to data compiled by heal...

Around 1.8 million Americans received COVID shots last week-IQVIA - Vimarsana News

Around 1.8 million Americans received COVID shots last week-IQVIA

(Reuters) - Around 1.8 million people in the United States received a COVID vaccine during the week ended Sept. 22, according to data compiled by heal...

Source: wsau.com
Explainer-What you need to know about RSV and the new vaccines - Vimarsana News

Explainer-What you need to know about RSV and the new vaccines

Advisers to the U.S. Centers for Disease Control and Prevention (CDC) are meeting on Friday to discuss recommendations for use of the first vaccine for respiratory syncytial virus (RSV) approved for pregnant women to protect their babies. That Pfizer shot and one developed by GSK in May became the first two RSV vaccines to win U.S. approval, for use in people aged 60 and over to prevent severe illness.

Source: yahoo.com
30 States Pause Medicaid Disenrollments After Glitch - Vimarsana News

30 States Pause Medicaid Disenrollments After Glitch

HHS has said 30 states must pause disenrollments from Medicaid and CHIP and reinstate coverage for people who lost it due to a glitch uncovered in August.

What you need to know about RSV and the new vaccines - Vimarsana News

What you need to know about RSV and the new vaccines

Expert advisers to U.S. Centers for Disease Control and Prevention on Friday recommended Pfizer's respiratory syncytial virus vaccine for women in the middle of the third trimester of pregnancy...